Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
40 studies found for:    Open Studies | "Hypotrichosis"
Show Display Options
Rank Status Study
1 Recruiting Safety and Efficacy of Bimatoprost 0.03% Solution for the Treatment of Thinning Eyebrows
Condition: Hypotrichosis
Interventions: Drug: Track A;   Drug: Track B
2 Recruiting Minoxidil Response Testing in Females With Female Pattern Hair Loss
Conditions: Alopecia;   Female Pattern Hair Loss
Intervention: Drug: 5% minoxidil topical foam
3 Recruiting Efficacy of Nutrition Supplement for Treatment of Men With Hair Loss
Condition: Androgenetic Alopecia
Interventions: Dietary Supplement: HCap Formula;   Dietary Supplement: Placebo
4 Recruiting Treatment of Androgenetic Alopecia in Males and Females
Condition: Androgenetic Alopecia
Interventions: Device: TopHat 655 rejuvenation system;   Device: Laser and/or Light Hair Rejuvenation System
5 Recruiting Intralesional Steroids in the Treatment of Alopecia Areata
Condition: Alopecia Areata
Interventions: Drug: Triamcinolone 2.5 mg/ml;   Drug: Triamcinolone 5 mg/ml;   Drug: Triamcinolone 10 mg/ml;   Drug: Intralesional Saline
6 Recruiting Minoxidil Response Testing in Males With Androgenetic Alopecia
Condition: Androgenetic Alopecia
Intervention: Drug: 5% minoxidil topical foam
7 Unknown  Pharmacogenomic Study of Androgenetic Alopecia
Condition: Androgenetic Alopecia
Intervention:
8 Recruiting A Study of the Safety, Tolerability, and Efficacy of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia (AGA)
Condition: Androgenetic Alopecia
Interventions: Drug: SM04554;   Drug: Vehicle
9 Recruiting Evaluating the Efficacy of Microneedling in the Treatment of Androgenetic Alopecia
Condition: Androgenetic Alopecia
Intervention: Device: topical 5% Minoxidil (Microneedling)
10 Recruiting Clinical Trial to Explore the Efficacy and Safety of DA-4001 After Topical Application
Condition: Androgenetic Alopecia
Interventions: Drug: DA-4001C;   Drug: 5% minoxidil
11 Unknown  The Comparison Study of Intralesional Botulinum Toxin A and Corticosteroid Injection for Alopecia Areata
Condition: Alopecia Areata
Interventions: Drug: Botulinum toxin type A;   Drug: Triamcinolone acetonide
12 Not yet recruiting Plasma Rich in Growth Factors (PRGF-Endoret)in the Treatment of Androgenetic Alopecia
Condition: Androgenetic Alopecia
Interventions: Device: PRGF-Endoret;   Other: Saline Solution
13 Unknown  The Efficacy in Treatment of Female Pattern Hair Loss Using 5% Minoxidil Solution Combinded With Zinc Supplement
Condition: Female Pattern Alopecia
Interventions: Drug: 15 mg Chelate zinc supplement;   Drug: Placebo drug supplement
14 Recruiting Alopecia Areata Registry
Conditions: Alopecia Areata;   Alopecia Totalis;   Alopecia Universalis;   Autoimmune Hair Loss;   Alopecia Partialis
Intervention:
15 Unknown  Stem Cell Educator Therapy in Alopecia Areata
Condition: Alopecia Areata
Intervention: Device: Stem Cell Educator
16 Recruiting Androgenetic Alopecia in Fabry Disease
Condition: Fabry Disease
Intervention:
17 Unknown  Split Wound Comparison of Trichophytic Closure Techniques for Donor Site in Hair Transplantation
Condition: Androgenetic Alopecia
Interventions: Procedure: Trichophytic closure upper edge trimming;   Procedure: Trichophytic closure lower edge trimming;   Procedure: Trichophytic closure both edge trimming
18 Unknown  24 Week Clinical Trial to Evaluate Safety and Effectiveness of a Hair Growth System to Treat Male and Female Baldness
Condition: Androgenetic Alopecia
Interventions: Device: iRestore Hair Rejuvenation System;   Device: sham device
19 Recruiting Sexual Function in Men Receiving Dutasteride for Androgenetic Alopecia
Condition: Alopecia
Interventions: Drug: Dutasteride;   Drug: Placebo
20 Not yet recruiting Bimatoprost Ophthalmic Solution in Increasing Eyebrow and Eyelash Growth in Patients Who Have Undergone Chemotherapy for Breast Cancer and in Healthy Participants
Conditions: Alopecia;   Breast Cancer
Interventions: Drug: bimatoprost ophthalmic solution;   Drug: placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years